Cybin Inc (NY: CYBN )
0.2640
-0.0040
(-1.49%)
Streaming Delayed Price
Updated: 11:26 AM EDT, Aug 26, 2024
Add to My Watchlist
All News about Cybin Inc
![](https://mms.businesswire.com/media/20230814537498/en/1867274/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/14/finance_and_psychedelics_anaterate_sergeitokmakov__by_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/11/psyched.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230814289210/en/1865806/22/Cybin_Side_Logo_%28004%29.jpg)
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/08/04/finance_and_psychedelics_publicdomainpictures_sergeitokmakov_by_pixabay_1.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230803104406/en/1859578/22/Cybin_Side_Logo_%28004%29.jpg)
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/07/31/psyched.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230802049248/en/1857003/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/01/aarons_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/01/finance_and_psychedelics_anaterate_sergeitokmakov__by_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/01/image36.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230801356442/en/1855946/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/01/image18_0.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://mms.businesswire.com/media/20230731210477/en/1855241/22/Cybin_Side_Logo_%28004%29.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230727946971/en/1852030/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230726659402/en/1850606/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/24/advanced_technology_clinic_dmt_psilocybin_mdma_aiyoshi597_gisele_yashar_bacsica_and_gorodenkoff_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230724779457/en/1847853/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/21/advanced_technology_clinic_dmt_psilocybin_mdma_bacsica_aiyoshi597_gisele_yashar_and_gorodenkoff_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230720070764/en/1846908/22/Cybin_Side_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.